As Novo prepares for critical clinical trial results due in December, the pressure is mounting, particularly after a 25% drop in stock value linked to lower-than-expected prescriptions for Wegovy and investor concerns (see chart below for drop marked)
Complete loss of appetite suppression occurring suddenly rather than gradually could indicate absorption problems or medication quality issues
Finally, never discontinue either medication abruptly without medical guidance
L-Carnitine supports the transport of fatty acids into mitochondria for energy production, which may help optimise fat metabolism
What the Clinical Trial Evidence Shows Phase 2 retatrutide trial data reported gastrointestinal effects as the most common adverse events
6 : 112 De Simone C, Catania S, Trinchieri V, Tzantzoglou S, Calvani M, Bagiella E